Abstract
Prevention is currently regarded a promising strategy for fighting the unfavorable consequences of psychosis. Yet, for the error probability inherent in any predictive approach, benefits and costs must be carefully weighed against each other. False attribution of risk may unnecessarily provoke stress and anxiety, and lead to unwarranted intervention exposure. However, clinical risk samples already exhibit psychopathological symptoms, cognitive and functional impairments, and help-seeking for mental problems. Thus, the risk of futile interventions is low as long as preventive measures also provide treatment for current complaints. Differentiation between still normal and clinically relevant mental states is another challenge as psychotic-like phenomena occur frequently in the general population, especially in younger adolescents. Reported prevalence rates vary with age, and if severe in terms of frequency and persistence, these phenomena considerably increase risk of psychosis in clinical as well as general population samples. Stigmatization is another concern, though insufficiently studied. Yet, at least more severe states of risk, which are accompanied by changes in thinking, feeling, and behavior, might lead to unfavorable, (self-) stigmatizing effects already by themselves, independent of any diagnostic “label,” and to stress and confusion for the lack of understanding of what is going on. To further improve validity of risk criteria, advanced risk algorithms combining multi-step detection and risk stratification procedures should be developed. However, all prediction models possess a certain error probability. Thus, whether a risk model justifies preventive measures can only be decided by weighing the costs of unnecessary intervention and the benefits of avoiding a potentially devastating outcome.
Similar content being viewed by others
References
Häfner H, van der Heiden W (2008) Course and outcome. In: Mueser KT, Jeste DV (eds) Clinical handbook of schizophrenia. The Guilford Press, New York, pp 100–113
Clouth J (2004) Kosten der Frühverrentung am Beispiel der Schizophrenie [Costs of early retirement—the case of schizophrenia]. Psychiatr Prax 31(Suppl 2):S238–S245
Rössler W et al (2005) Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol 15(4):399–409. doi:10.1016/j.euroneuro.2005.04.009
Brown S et al (2010) Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 196(2):116–121. doi:10.1192/bjp.bp.109.067512
Gutiérrez-Maldonado J, Caqueo-Urízar A, Kavanagh D (2005) Burden of care and general health in families of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 40(11):899–904
Gustavsson A et al (2011) Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21(10):718–779. doi:10.1016/j.euroneuro.2011.08.008
Tandon R, Nasrallah HA, Keshavan MS (2010) Schizophrenia, “just the facts” 5. Treatment and prevention. Past, present, and future. Schizophr Res 122(1–3):1–23. doi:10.1016/j.schres.2010.05.025
WHO (2004) Prevention of mental disorders: effective interventions and policy options. World Health Organization, Geneva
Ruhrmann S et al (2012) Pharmacological prevention and treatment in clinical at-risk states for psychosis. Curr Pharm Design 18(4):550–557
Schultze-Lutter F et al (2007) Predicting first-episode psychosis by basic symptom criteria. Clin Neuropsychiatry 4(1):11–22
Schultze-Lutter F et al (2007) Schizophrenia proneness instrument—adult version (SPI-A). Giovanni Fioriti, Rome
McGlashan T, Walsh B, Woods SW (2010) The psychosis-risk syndrome. Handbook for diagnosis and follow-up. Oxford University Press, New York
Yung AR et al (2005) Mapping the onset of psychosis: the comprehensive assessment of At-Risk Mental States. Aust N Z J Psychiatry 39(11–12):964–971
van Os J, Rutten BP, Poulton R (2008) Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull 34(6):1066–1082. doi:10.1093/schbul/sbn117
Ruhrmann S, Schultze-Lutter F, Klosterkötter J (2010) Probably at-risk, but certainly ill–advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res 120(1–3):23–37. doi:10.1016/j.schres.2010.03.015
Morrison AP et al (2012) Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ 344:e2233. doi:10.1136/bmj.e2233
Schultze-Lutter F et al (2012) “A rose is a rose is a rose”, but at-risk criteria differ. Pychopathology. doi:10.1159/000339208
Yung AR et al (2007) Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 33(3):673–681. doi:10.1093/schbul/sbm015
Fusar-Poli P et al (2012) Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 69(3):220–229. doi:10.1001/archgenpsychiatry.2011.1472
Kirkbride JB et al (2006) Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry 63(3):250–258. doi:10.1001/archpsyc.63.3.250
Klosterkötter J et al (2001) Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 58(2):158–164. doi:10.1001/archpsyc.58.2.158
Häfner H et al (1998) The ABC Schizophrenia Study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol 33(8):380–386
Schultze-Lutter F et al (2010) Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull 36(1):182–191. doi:10.1093/schbul/sbn072
Ruhrmann S, Schultze-Lutter F, Klosterkötter J (2010) Sub-threshold states of psychosis—a challenge to diagnosis and treatment. Clin Neuropsychiatry 7(2):72–87
McGlashan TH et al (2007) Recruitment and treatment practices for help-seeking “prodromal” patients. Schizophr Bull 33(3):715–726. doi:10.1093/schbul/sbm025
Klosterkötter J, Schultze-Lutter F (2010) Prevention and early treatment. In: Helmchen H, Sartorius N (eds) Ethics in psychiatry: European contributions. Springer + Business Media B.V, Heidelberg, pp 235–262
Bodatsch M et al (2011) Prediction of psychosis by mismatch negativity. Biol Psychiatry 69(10):959–966. doi:10.1016/j.biopsych.2010.09.057
Pukrop R, Ruhrmann S (2012) Neurocognitive indicators of high-risk states for psychosis. In: Borgwardt S, McGuire P, Fusar Poli P (eds) Vulnerability to psychosis :from neurosycience to psychopathology. Psychology Press, Hove, pp 73–94
Koutsouleris N et al (2009) Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry 66(7):700–712. doi:10.1001/archgenpsychiatry.2009.62
Ruhrmann S et al (2008) Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatr Scand 117(5):357–368. doi:10.1111/j.1600-0447.2008.01152.x
APA (2010) DSM-V development: attenuated psychosis syndrome (proposed for section III of the DSM-5). http://www.dsm5.org/proposedrevision/Pages/proposedrevision.aspx?rid=412. Accessed 29 May 2012
Ruhrmann S et al (2011) Negative symptoms and transition to a first episode of psychosis-findings from EPOS. Schizophr Bull 37:20–21
Addington J et al (2011) At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 168(8):800–805. doi:10.1176/appi.ajp.2011.10081191
van Os J et al (2009) A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 39(2):179–195. doi:10.1017/S0033291708003814
Yung AR, McGorry PD (1996) The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 22(2):353–370
van Os J et al (2000) Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res 45(1–2):11–20. doi:10.1016/S0920-9964(00)90323-2
Spauwen J et al (2003) Sex differences in psychosis: normal or pathological? Schizophr Res 62(1–2):45–49
Kendler KS et al (1996) Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry 53(11):1022–1031
Kelleher I et al (2011) Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. Schizophr Bull. doi:10.1093/schbul/sbr164
Kelleher I et al (2012) Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br J Psychiatry 201:26–32. doi:10.1192/bjp.bp.111.101543
Schultze-Lutter F, Michel C, Schimmelmann BG (2012) Prevalence of at-risk criteria of psychosis in the general population: preliminary results from a telephone survey. Schizophr Res 136(Suppl 1):314
Schimmelmann BG, Michel C, SchultzeLutter F (2012) Psychopathological significance of at-risk criteria of psychosis in the general population: preliminary results from a telephone survey. Schizophr Res 136(Suppl 1):310
Schimmelmann BG, Walger P, Schultze-Lutter F (in press) Significance of prodromal symptoms of schizophrenia in childhood and adolescence. Can J Psychiatr
Werbeloff N et al (2012) Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life. Arch Gen Psychiatry 69(5):467–475. doi:10.1001/archgenpsychiatry.2011.1580
Kaymaz N et al (2012) Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? Psychol Med 1–15. doi:10.1017/S0033291711002911
Ochoa S et al (2008) What is the relative importance of self reported psychotic symptoms in epidemiological studies? Results from the ESEMeD–Catalonia Study. Schizophr Res 102(1–3):261–269. doi:10.1016/j.schres.2008.04.010
Schultze-Lutter F, Schimmelmann BG, Ruhrmann S (2011) The near Babylonian speech confusion in early detection of psychosis. Schizophr Bull 37(4):653–655. doi:10.1093/schbul/sbr039
Grano N et al (2011) Differential results between self-report and interview-based ratings of risk symptoms of psychosis. Early Interv Psychiatry 5(4):309–314. doi:10.1111/j.1751-7893.2011.00266.x
Kendell R, Jablensky A (2003) Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 160(1):4–12
Ben-Zeev D, Young MA, Corrigan PW (2010) DSM-V and the stigma of mental illness. J Ment Health 19(4):318–327. doi:10.3109/09638237.2010.492484
Welsh P, Tiffin PA (2011) Observations of a small sample of adolescents experiencing an at-risk mental state (ARMS) for psychosis. Schizophr Bull. doi:10.1093/schbul/sbr139
Nordt C, Rössler W, Lauber C (2006) Attitudes of mental health professionals toward people with schizophrenia and major depression. Schizophr Bull 32(4):709–714. doi:10.1093/schbul/sbj065
Gaebel W, Zaske H, Baumann AE (2006) The relationship between mental illness severity and stigma. Acta Psychiatr Scand Suppl 429:41–45. doi:10.1111/j.1600-0447.2005.00716.x
Penn DL, Kohlmaier JR, Corrigan PW (2000) Interpersonal factors contributing to the stigma of schizophrenia: social skills, perceived attractiveness, and symptoms. Schizophr Res 45(1–2):37–45
Corcoran C, Malaspina D, Hercher L (2005) Prodromal interventions for schizophrenia vulnerability: the risks of being “at risk”. Schizophr Res 73(2–3):173–184
APA (2003) Diagnostisches und Statistisches Manual Psychischer Störungen-Textrevision (DSM-IV-TR). Hogrefe, Göttingen
Ruhrmann S et al (2010) Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 67(3):241–251. doi:10.1001/archgenpsychiatry.2009.206
Riecher-Rössler A et al (2009) Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biol Psychiatry 66(11):1023–1030. doi:10.1016/j.biopsych.2009.07.020
Job DE et al (2006) Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Med 4:29
Klosterkötter J et al (2011) Prediction and prevention of schizophrenia: what has been achieved and where to go next? World Psychiatry 10(3):165–174
Acknowledgments
This article is part of the supplement “Personalized Psychiatry and Psychotherapy.” This supplement was not sponsored by outside commercial interests. It was funded by the German Association for Psychiatry and Psychotherapy (DGPPN).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ruhrmann, S., Klosterkötter, J., Bodatsch, M. et al. Chances and risks of predicting psychosis. Eur Arch Psychiatry Clin Neurosci 262 (Suppl 2), 85–90 (2012). https://doi.org/10.1007/s00406-012-0361-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-012-0361-4